Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute.

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

Copyright © 2015 Cengage Learning® Chapter 15 Urinary System Drugs.
1. Describe the pathogenesis of hyperuricemia and gout Goup C1 Group C1.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
GOUT AND PSEUDOGOUT ANDRES QUICENO, MD Rheumatology Division
Lesch-Nyhan Syndrome (LNS) By: Amir Sadafi and Bela Mohapatra.
Purine Degradation & Gout (Musculoskeletal Block)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Gout.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
DR. ABDULRAHMAN AL-AJLAN
Gout: Its not all crystal clear Robert L. Wortmann, M.D. Department of Internal Medicine The University of Oklahoma College of Medicine, Tulsa.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Purine degradation & Gout (Musculoskeletal Block).
Gout Dr. Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Uric acid xiaoli.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric Acid Metabolism & Gout
HYPERURICEMIA and GOUT PATHOGENESIS. HYPERURICEMIA Plasma/serum urate concentration >408 mol/L (6.8 mg/dL) Present in between 2.0 and 13.2% of ambulatory.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Gout Gouty Arthritis By Mike Parenteau.
Obstructive Uropathy Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 20 Nonopioid Analgesics, Nonsteroidal Antiinflammatories, and Antigout Drugs.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Agents Used to Treat Hyperuricemia and Gout
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
History A 50 y/o was referred for evaluation of azotemia. 10 yrs ago, he experienced sudden onset of pain on his right big toe. His serum uric acid was.
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
Dr. Aya M. Serry Renal Failure Renal failure is defined as a significant loss of renal function in both kidneys to the point where less than 10.
Renal Pathophysiology III : Diseases that affect the kidney and urinary tract Acute and chronic renal failure.
PA Days Presentation Brian K. Shrawder, PA-S LHU.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Dr. Müge Bıçakçıgil Kalaycı
StagesClinical Features (1)Asymptomatic hyperuricemiahigh uric acid level is present but without symptoms (2) Acute Gouty Arthritishigh uric acid level.
Blood Urea Nitrogen (BUN) T.A. Bahiya Osrah. Introduction Many factors can affect on kidney function leads to kidneys damage. –Diabetes –high blood pressure.
Gout is a species-wide inborn error of purine metabolism D. Branch Moody, M.D. Professor of Medicine Immunology Laboratory, Smith Building
Gout. The term gout describes a disease spectrum including – hyperuricemia, – recurrent attacks of acute arthritis associated with monosodium urate crystals.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
Lab (4): Renal Function test (RFT) Lecturer Nouf Alshareef KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2012
Lab (4): Renal Function test (RFT) Lecturers: Nouf Alshareef and Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
Colchicine: Colchicine: Effective & specific gout Rx, but less favored than NSAIDs because of slow onset of action & high incidence of side effects. Effective.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
GERIATRICS Dr. Meg-angela Christi Amores. Musculoskeletal Disorders in the Elderly  Osteoarthritis  Rheumatoid Arthritis  Gout (Gouty arthritis) 
Be Aware Of Various Gout Treatments. Gout is a painful condition caused by a rise in the uric acid level in the blood. The uric acid that accumulates.
Uric acid nephropathy 신장내과 R4 최선영. Endogenous production of uric acid Purine catabolism hypoxanthine xanthine Uric acid allantoin XO UO allopurinol -
Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Crystalopathies Joanna Zalewska.
Gout Is recurrent inflammatory disorder characterized by
Gout.
History Salient Features Physical Exam
Pathology for year 2, unit 3
Drug Therapy of Gout 1.
Disorders of Renal System
  URIC ACID Muthana A. Al-Shemeri.
Antiuricaemic drugs Dr A.W Olusanya.
Gouty Nephropathy American Journal of Kidney Diseases
Gout Scott Smith PGY-1 1/11/2018.
Purine Degradation & Gout (Musculoskeletal Block)
Purine Degradation & Gout (Musculoskeletal Block)
Presentation transcript:

Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute gouty arthritis Hyperuricemia has caused the deposit of uric acid crystals in joint spaces Sudden onset of intense pain and swelling in the joints, which also may be warm and very tender Attack commonly occurs at night Triggered by ○ Stressful events, alcohol or drugs, or the presence of another illness Harrison’s Principles of Internal Medicine 17 th edition

Four Stages of Gout  Interval/Intercritical gout period between acute attacks no symptoms normal joint function  Chronic Tophaceous gout most disabling stage of gout over a long period (10 years) disease has caused permanent damage to the affected joints and sometimes to the kidneys Solid deposits of urate crystals in joints, usually in the big toe (Tophi) ○ Low grade pain and mild and acute inflammation ○ May progress to affect other joints Uric acid nephrolithiasis ○ Very painful Harrison’s Principles of Internal Medicine 17 th edition

Conditions which Contribute to Hyperuricemia ↑Production ↓ExcretionCombination Purine-rich dietRenal insufficiencyG6PD Alcohol Strenuous exerciseDiabetes insipidus Enzyme deficiencies (e.g Lesch-Nyhan and Kelley Seegmiller syndrome) Drugs: Salicylates (>2 g/d), diuretics, anti- TB,levodopa,nicotinic acid, cyclosporine Fructose-1-phosphate aldolase deficiency Lymphoproliferative & Myeloproliferative diseases Polycystic kidney diseaseShock Hemolytic diseasesAcidosis Polycythemia veraLead intoxication PsoriasisHyperparathyroidism; Hypothyroidism Paget's diseaseToxemia of pregnancy Glycogenosis III, V, and VIIDown syndrome Berylliosis;Sarcoidosis; Bartter's syndrome Hyperuricemia, Yasir Qazi, MD. Retrieved from Harrison’s Principles of Internal Medicine 17 th edition

Renal Involvement in Chronic Gout  Uric Acid Nephrolithiasis Occurs most commonly, but not exclusively, in individuals with gout In gout, prevalence correlates with the serum and urinary uric acid levels o ~50% with serum urate levels of 770 mol/L (13 mg/dL) or o Urinary uric acid excretion >6.5 mmol/d (1100 mg/d) Uric acid can also play a role in other types of kidney stones o May act as a nidus on which calcium oxalate can precipitate o Lower the formation product for calcium oxalate crystallization  Urate Nephropathy (Urate Nephrosis) Late manifestation of severe gout Characterized histologically by MSU crystal deposits surrounded by a giant cell inflammatory reaction in the medullary interstitium and pyramids Rare; cannot be diagnosed in the absence of gouty arthritis Lesions may be clinically silent or cause proteinuria, hypertension, and renal insufficiency Harrison’s Principles of Internal Medicine 17 th edition

Renal Involvement in Chronic Gout  Uric Acid Nephropathy Reversible cause of acute renal failure due to precipitation of uric acid in renal tubules and collecting ducts  obstruction to urine flow Dehydration and acidosis favor uric acid crystal formation Develops following sudden urate overproduction and marked hyperuricaciduria Uric acid : creatinine in random urine sample or 24-h specimen is >1 Hypertension Uric acid appears to activate the renin-angiotensin system and inhibit NO, leading to glomerular hypertension and renal injury Harrison’s Principles of Internal Medicine 17 th edition Teng, G.G., Nair, R. & Saag, K.G. (2006). Pathophysiology, clinical presentation and treatment of gout. Drugs. 66 (12),

Outline Management of Uncomplicated Acute Gout. What analgesics are contraindicated in this patient? MMainstay of treatment during an acute attack is the administration of: Nonsteroidal anti-inflammatory drugs (NSAIDs) Colchicine Glucocorticoids In attacks involving one or two joints, intraarticular glucocorticoid injections may be preferable and effective. Ice pack applications and rest of the involved joints can be helpful. What analgesics are contraindicated in this patient? NSAIDS Ibuprofen Naproxen Diclofenac Licofelone Harrison’s Principles of Internal Medicine 17 th edition